Functional neuroimaging of minocycline's effect in a patient with schizophrenia
Cristiano Chaves(Queen's University), Jaime E. C. Hallak(Universidade de Ribeirão Preto), José Alexandre S. Crippa(Universidade de Ribeirão Preto), Lauro Wichert‐Ana(Universidade de Ribeirão Preto), Kathryn G. Todd(University of Alberta), Emerson Nobuyuki Itikawa(Universidade de São Paulo), Glen B. Baker(Women and Children’s Health Research Institute), João Paulo Maia‐de‐Oliveira(Universidade Federal do Rio Grande do Norte), Serdar Dursun(University of Alberta), Antônio Waldo Zuardi(Universidade de Ribeirão Preto), Cristiane Reberte de Marque(Universidade de Ribeirão Preto)
Progress in Neuro-Psychopharmacology and Biological Psychiatry
February 9, 2010
Cited by 23
Related Papers
Treatment-Resistant Schizophrenia: Treatment Response and Resistance in Psychosis (TRRIP) Working Group Consensus Guidelines on Diagnosis and Terminology
|American Journal of Psychiatry|2016|1.1k
Rapid antidepressant effects of the psychedelic ayahuasca in treatment-resistant depression: a randomized placebo-controlled trial
|Psychological Medicine|2018|819
Cannabidiol Reduces the Anxiety Induced by Simulated Public Speaking in Treatment-Naïve Social Phobia Patients
|Neuropsychopharmacology|2011|763
Neural basis of anxiolytic effects of cannabidiol (CBD) in generalized social anxiety disorder: a preliminary report
|Journal of Psychopharmacology|2010|530
Antidepressant effects of a single dose of ayahuasca in patients with recurrent depression: a preliminary report
|Brazilian Journal of Psychiatry|2015|484